1. Aldose reductase inhibitor protects mice from alcoholic steatosis by repressing saturated fatty acid biosynthesis
   Chang Guo et al, 2018, Chemico-Biological Interactions CrossRef
2. Aldose Reductase Inhibitors of Plant Origin in the Prevention and Treatment of Alcoholic Liver Disease: A Minireview
   Longxin Qiu et al, 2019, BioMed Research International CrossRef
3. Bouchardatine analogue alleviates non‐alcoholic hepatic fatty liver disease/non‐alcoholic steatohepatitis in high‐fat fed mice by inhibiting ATP synthase activity
   Yong Rao et al, 2019, Br J Pharmacol CrossRef
4. null
   Himangshu Sonowal et al, 2019 CrossRef
5. The Inhibition of Aldose Reductase Accelerates Liver Regeneration through Regulating Energy Metabolism
   Chang Xian Li et al, 2020, Oxidative Medicine and Cellular Longevity CrossRef
6. Rosmarinic acid alleviates ethanol-induced lipid accumulation by repressing fatty acid biosynthesis
   Chang Guo et al, 2020, Food Funct. CrossRef
7. Does the breakdown of the detoxification system for aldehydes as a result of aldose reductase upregulation lead to alcohol‐induced liver injury in humans and mice?
   Nigishi Hotta et al, 2020, J Diabetes Investig CrossRef
8. Myricitrin ameliorates ethanol-induced steatosis in mouse AML12 liver cells by activating AMPK, and reducing oxidative stress and expression of inflammatory cytokines
   Jing Gao et al, 2018, Mol Med Report CrossRef
9. Cerebral Fructose Metabolism as a Potential Mechanism Driving Alzheimer’s Disease
   Richard J. Johnson et al, 2020, Front. Aging Neurosci. CrossRef
10. Elevated Fructose and Uric Acid Through Aldose Reductase Contribute to Experimental and Human Alcoholic Liver Disease.
    Min Wang et al, 2020, Hepatology CrossRef
11. Hepatoprotective Effects of the Cichorium intybus Root Extract against Alcohol-Induced Liver Injury in Experimental Rats
    Jihee Kim et al, 2021, Evidence-Based Complementary and Alternative Medicine CrossRef
12. Development of Aldose Reductase Inhibitors for the Treatment of Inflammatory Disorders and Cancer: Current Drug Design Strategies and Future Directions
    Himangshu Sonowal et al, 2021, CMC CrossRef
13. Recent Progress on Fructose Metabolism—Chrebp, Fructolysis, and Polyol Pathway
    Katsumi Iizuka, 2023, Nutrients CrossRef
14. Alcohol, White Adipose Tissue, and Brown Adipose Tissue: Mechanistic Links to Lipogenesis and Lipolysis
    Qing Li et al, 2023, Nutrients CrossRef
15. Caulerpa lentillifera improves ethanol-induced liver injury and modulates the gut microbiota in rats
    Kuan-Yu Lin et al, 2023, Current Research in Food Science CrossRef
16. Natural Compounds with Aldose Reductase (AR) Inhibition: A Class of Medicative Agents for Fatty Liver Disease
    Tong Wang et al, 2023, CCHTS CrossRef
17. Intestinal microbiome-targeted therapies improve liver function in alcohol-related liver disease by restoring bifidobacteria: a systematic review and meta-analysis
    Xin Chi et al, 2024, Front. Pharmacol. CrossRef
18. Transcriptomic analysis reveals pharmacological mechanisms mediating efficacy of Yangyinghuoxue Decoction in CCl4-induced hepatic fibrosis in rats
    Yanming Bai et al, 2024, Front. Pharmacol. CrossRef